Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-057685
Date:2019-11-19
Issuer: CRISPR THERAPEUTICS AG (CRSP)
Original Submission Date:

Reporting Person:

BOLZON BRADLEY J PHD
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON SHARES 2019-11-19 S 13,745 d $67.41 0 direct
COMMON SHARES 2019-11-19 S 28,255 d $67.41 596,741 indirect f3
COMMON SHARES 2019-11-19 0 $0.00 1,192,139 indirect f4
COMMON SHARES 2019-11-19 0 $0.00 34,977 indirect f5
COMMON SHARES 2019-11-19 0 $0.00 38,772 indirect f6
COMMON SHARES 2019-11-19 0 $0.00 90,730 indirect f7
COMMON SHARES 2019-11-19 0 $0.00 2,238,979 indirect f8
COMMON SHARES 2019-11-19 0 $0.00 13,277 indirect f9
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $62.35 to $73.75, inclusive. the reporting person undertakes to provide to crispr therapeutics ag, any security holder of crispr therapeutics ag, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price.
f3 these securities are held of record by versant venture management, llc ("vvm llc"). the reporting person is a managing member of vvm llc and pursuant to agreement with vvm llc, the reporting person is deemed to hold these securities for the benefit of vvm llc. accordingly, vvm llc may be deemed to be the indirect beneficial owner of these securities, and the reporting person may be deemed to indirectly beneficially own the securities through his interest in vvm llc. the reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
f4 these securities are held of record by versant venture capital v, l.p. ("vvc v"). versant ventures v, llc ("vv v") is the sole general partner of vvc v and may be deemed to have voting and investment power over the securities held by vvc v and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a managing director of vv v and may be deemed to indirectly beneficially own the securities through his interest in vv v. the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
f5 these securities are held of record by versant affiliates fund v, l.p. ("vaf v"). versant ventures v, llc ("vv v") is the sole general partner of vaf v and may be deemed to have voting and investment power over the securities held by vaf v and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a managing director of vv v and may be deemed to indirectly beneficially own the securities through his interest in vv v. the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
f6 these securities are held of record by versant ophthalmic affiliates fund i, l.p. ("voa"). vv v is the sole general partner of voa and may be deemed to have voting and investment power over the securities held by voa and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a managing director of vv v and may be deemed to indirectly beneficially own the securities through his interest in vv v. the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
f7 these securities are held of record by versant venture capital v (canada) lp ("vvc can"). versant ventures v gp-gp (canada), inc. ("vv v can gp") is the sole general partner of versant ventures v (canada), l.p. ("vv v can") and vv v can is the sole general partner of vvc can. vv v can gp and vv v can may be deemed to have voting and investment power over the securities held by vvc can and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a director of vv v can gp and may be deemed to indirectly beneficially own the shares through his interest in vv v can gp. the reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein, if any.
f8 these securities are held of record by versant venture capital iv, l.p. ("vvc iv"). versant ventures iv, llc ("vv iv") is the sole general partner of vvc iv and may be deemed to have voting and investment power over the securities held by vvc iv and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a managing director of vv iv and may be deemed to indirectly beneficially own the securities through his interest in vv iv. the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
f9 these securities are held of record by versant side fund iv, l.p. ("vsf iv"). vv iv is the sole general partner of vsf iv and may be deemed to have voting and investment power over the securities held by vsf iv and as a result may be deemed to have beneficial ownership over such securities. the reporting person is a managing director of vv iv and may be deemed to indirectly beneficially own the securities through his interest in vv iv. the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
WhaleWisdom Logo

Elevate your investments